| Similar Articles |
|---|
 |
The Motley Fool
December 31, 2010
Brian Orelli |
3 Biotech 2010 IPOs Worthy of a Look These IPOs are worth a spot on your watchlist.   |
The Motley Fool
August 11, 2009
Brian Orelli |
A Drug Stock IPO! Finally! Today's offering, Cumberland Pharmaceuticals is in a special breed of small drugmakers: it's actually profitable. |
The Motley Fool
February 4, 2010
Brian Orelli |
A Drugless Drugmaker IPO! Biotech investors embrace risk ... sort of. The most exciting thing about Ironwood's IPO? The company doesn't have any drugs on the market. |
The Motley Fool
December 4, 2007
Brian Orelli |
An Early Gift to Drugmakers Drugmakers could be allowed to market for drugs' off-label indications. |
The Motley Fool
December 28, 2007
Brian Orelli |
The Biggest Health-Care IPOs of 2007 Let's take a look at four of the most intriguing health care IPOs from 2007. |
The Motley Fool
September 25, 2008
Brian Lawler |
Eli Lilly's Dose of Disclosure The pharmaceutical pledges public reports of its dealings with doctors. |
The Motley Fool
January 18, 2005
Charly Travers |
Biotech Class of 2004 Hot drugs are leading to amazing stock performances. CoTherix... Eyetech Pharmaceuticals... Pharmion... etc. |
The Motley Fool
January 25, 2005
Charly Travers |
Grading Old-School Biotech Be very wary of biotech IPOs from companies lacking drugs. |
The Motley Fool
April 5, 2005
Tom Taulli |
Fastclick's Slow IPO Is this an opportunity for investors? Before jumping into Fastclick, you need to look at the fundamentals in order to discern whether an opportunity does indeed exist. |
The Motley Fool
August 23, 2004
Bill Mann |
Google: The Scorecard The most anticipated IPO in history has passed. After all the hype and garment rending, how'd it go? |
The Motley Fool
April 18, 2006
Tom Taulli |
An ETF for New Stocks IPOs become the latest to join the ETF party. The IPOX-100 Index Fund is essentially a mid-cap index -- with a nice marketing angle. |
The Motley Fool
September 23, 2005
W.D. Crotty |
A Taste of IPO Indigestion Hot restaurant IPOs Ruth's Chris and Kona Grill quickly cool down. Investors should acknowledge a fundamental truth -- when an investment bank prices an IPO, they usually have enough information to determine the company's fair value. |
The Motley Fool
December 17, 2008
Selena Maranjian |
The Sweet and Sour of IPOs Getting in on an IPO early is no surefire path to riches. It's usually best to wait until the dust settles and you have enough information to be very confident in the company's future. |
The Motley Fool
June 30, 2011
Brian Orelli |
2 Backdoor Biotech IPOs to Watch Just don't buy yet. |
HBS Working Knowledge
April 11, 2005
Nayantara Hensel |
Are Dutch Auctions Right for Your IPO? It worked for Google, but would a Dutch auction process work for your IPO? Here are some things to consider before following in the search engine's footsteps. |
The Motley Fool
July 17, 2007
Zoe Van Schyndel |
This ETF Makes IPOs Fashionable Want to buy into going-public mania? Here's a simple option. FPX tracks the U.S. IPOX-100 Index, which includes the 100 largest, typically best-performing, and most liquid IPOs in the U.S. |
The Motley Fool
November 30, 2011
Travis Hoium |
What Is a Good IPO? The success of an IPO really depends on your point of view. |
The Motley Fool
December 20, 2004
W.D. Crotty |
That Post-IPO Headache Could the fate of some of June's hot IPOs be an ill omen for today's IPO hotties? |
The Motley Fool
December 29, 2003
Selena Maranjian |
IPOs Heating Up Expect many debutante firms soon. |
CFO
October 1, 2004
Roy Harris |
Maybe Next Year After a sharp uptick in filings early in the year, the IPO market slowed again this summer. The failure of the Google IPO is just one example that confirms the market wants steak, not sizzle. |
The Motley Fool
October 2, 2009
Brian Orelli |
A Plasma-tastic IPO Talecris Biotherapeutics debuted on the public markets yesterday, raising $950 million for the company. That's the second largest IPO of the year so far. |
Financial Advisor
October 2010
IPOs Are Back |
IPOs Are Back Deal volume is up, but performance is iffy. Upcoming deals include GM, LPL and maybe Facebook. |
The Motley Fool
May 3, 2011
Dan Caplinger |
Be a Smarter IPO Investor Some IPOs soar and others bomb. Be aware of the traps. |
The Motley Fool
November 17, 2005
W.D. Crotty |
SunPower Shines The solar cell manufacturer soars 40% above its initial offering price. Cypress Semiconductor is the big winner here. Even at the IPO price, its stake in SunPower is now valued at a dazzling $936 million. |
The Motley Fool
May 18, 2011
Esterhuizen & Sellitti |
IPO Watch: The Best- and Worst-Performing IPOs Over the Last Year IPOs can be profitable, but they also come with their fair share of risk. |
Financial Planning
March 1, 2012
Donald Jay Korn |
First Impressions Not every planner will want to delve deeply into individual IPOs. A simpler approach to IPOs is simply to wait and see. "Waiting is prudent," Krapfel says. "You'll want to see an economic moat to keep out competitors, and you'd like to see profits." |
The Motley Fool
October 6, 2004
W.D. Crotty |
2 IPOs Priced to Perfection These IPOs had grand welcomes: Steakhouse operator Texas Roadhouse... Biopharmaceutical Theravance... |
The Motley Fool
March 3, 2009
Rick Aristotle Munarriz |
Why Aren't Facebook and Twitter Public? The markets need these two companies more than they need the markets. |
The Motley Fool
July 29, 2009
Selena Maranjian |
Should You Be an Instant IPO Investor? Not all IPOs perform spectacularly. If you do decide to invest in them, be choosy. Yes, many will be unspectacular performers. But some will shine. |
The Motley Fool
June 4, 2010
Bruce V. Bigelow |
Looking for an Exit What are the factors affecting IPOs, and what kind of guidance are experienced CEOs and other experts offering about taking startups public? Startup founders, investors, and bankers offer some IPO guidance. |
The Motley Fool
June 1, 2010
Dan Caplinger |
Should You Stop Buying New Stocks? Private equity IPOs have done badly. |
The Motley Fool
August 18, 2004
Bill Mann |
What's Google Minus $10 Billion? The company drops its price and shares offered. Its magic: turning the hottest IPO in history into a disaster. |
Entrepreneur
November 2007
Mark Henricks |
The Give and Take of Stocks Tech companies top the list in IPO and M&A deals. |
InternetNews
May 22, 2009
Christopher Saunders |
OpenTable IPO: Soaring Debut, Booming Hype Remind you of anything - say, early 2000s dot-com valuations? Let's not get carried away. |
The Motley Fool
August 19, 2004
Bill Mann |
Being Frugal With Google Google begins trading. Finally. If the company's value is to match its price at current levels, it has to achieve a nearly unequaled level of growth for a large company. |
BusinessWeek
July 23, 2007
Aaron Pressman |
A Leaner Upside For Outsiders The market for initial public offerings is booming again. That's great news for companies issuing shares - and bad news for most of the people buying them. |
Entrepreneur
July 2008
Carol Tice |
Bouncing Back When IPO plans flop, companies in need of capital find new ways to make financing work. |
The Motley Fool
December 18, 2006
Matt Koppenheffer |
Nice: Credit Suisse Investment Banking Of the active IPO underwriters, Credit Suisse had a really nice year, with its average IPO returning 33%. Investors, take note. |
The Motley Fool
September 30, 2009
Brian Orelli |
This IPO Is Sluggish Is it just a little cold or something more serious? Select Medical Holdings' IPO on Friday was downright sick. |
The Motley Fool
May 8, 2007
Tom Taulli |
Bidding Online for Hot IPOs More companies are giving individual investors a shot at new shares. For smart investors, investing is still about picking solid companies, not finding a trading advantage on an IPO. |
Pharmaceutical Executive
October 1, 2005
Christopher Lisanti |
Physician Frustration Doctors have had enough. But reps can still redeem themselves. As the industry thinks about new sales force models, it should look beyond ROI numbers, toward a new paradigm that not only works for pharma, but also for its customers. |
The Motley Fool
May 25, 2011
Rick Aristotle Munarriz |
Underwriters Get Raked Over the Coals A hot IPO doesn't mean an investment banker should be burned at the stake. |
The Motley Fool
March 8, 2006
Tim Hanson |
IPOs' Dirty Little Secret There's optimism around the market's newest offerings, but is it warranted? Many IPOs just flat out fail to perform over long periods of time. Investors -- never buy the hype and never overpay. |
The Motley Fool
January 21, 2010
Selena Maranjian |
Why You Shouldn't Care About IPOs Don't get overly excited by initial public offerings. |
The Motley Fool
December 12, 2003
Tom Taulli |
The Ka-Ching Dynasty? Ctrip.com is too hot, but 2004 could be the year of the China IPO. |
The Motley Fool
September 22, 2006 |
The IPO Lock-Up Period Before you get involved in an initial public offering, learn how IPOs work. |
Inc.
April 1, 2002
Kenneth Klee |
Buy Now, Pay Later Just because you want your company to have an IPO doesn't mean you should invest in someone else's. Unless you do it like this... |
The Motley Fool
April 3, 2009
Rick Aristotle Munarriz |
Come On In, the Water's Fine The time is ripe for new IPOs. |
Pharmaceutical Executive
August 1, 2005 |
Backpage: Feet-on-the-Street Interview A new survey asked pharmaceutical reps how their job has been changing. One bit of good news: A few reps think it's easier to get past the receptionist's desk. |
The Motley Fool
August 17, 2004
Roger Nusbaum |
Google Showered With Pessimism There may be too much doubt surrounding the big IPO. |
